Durwood Neal, MD
Urology · Arlington, TXNPI 1801842539
Payments from drug & device makers
Across 52 payments — averaging $117.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Intuitive Surgical$2K
- Procept Biorobotics Corporation$629
- Neotract Inc.$342
- Cook Medical LLC$190
- Boston Scientific$183
- plus $634 from 17 others
What the payments were for
- Travel & lodging$60917%
- Food & beverage$1,48641%
- Education$1,51242%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 4 | $2,525 |
| Intuitive Surgical | 3 | $1,628 |
| Procept Biorobotics Corporation | 5 | $629 |
| Neotract Inc. | 3 | $342 |
| Cook Medical LLC | 2 | $190 |
| Boston Scientific | 4 | $183 |
| Axonics, Inc. | 5 | $145 |
| Palette Life Sciences, Inc. | 1 | $82 |
| Medtronic | 4 | $61 |
| Ambu Inc. | 1 | $42 |
| Novartis | 3 | $42 |
| Baxter Healthcare | 2 | $40 |
| Octapharma USA, Inc. | 1 | $26 |
| Novo Nordisk | 1 | $24 |
| Travere Therapeutics, Inc. | 5 | $23 |
| Photocure Inc | 1 | $22 |
| Coloplast | 1 | $22 |
| Bayer | 1 | $21 |
| Dornier Medtech America, Inc | 1 | $20 |
| Covidien LP | 1 | $18 |
| Johnson & Johnson | 1 | $17 |
| Olympus America Inc. | 1 | $15 |
| Agiliti Surgical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,132 in reported general payments places this provider in the 60th percentile of 878 urology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 57 | $972 |
| Finasteride | 23 | $497 |
| Oxybutynin Chloride ErOxybutynin Chloride | 19 | $155 |
| Ciprofloxacin Hcl | 20 | $86 |
Paid to pharmacies, not to this prescriber.
Other urology in Arlington
- Andrew SunArlington$291K
- James VestalArlington$290K
- Harrison AbrahamsArlington$159K
- Zvi SchiffmanHouston$17.8M
- Jose de la CerdaSan Antonio$9M
- Daniel SaltzsteinSan Antonio$5.8M
- Jose KaramHouston$5.7M
- Daniel ZainfeldSan Antonio$4.7M
- Brian MazzarellaLakeway$4.5M
- Andrew von EschenbachMontgomery$3.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.